"Renalism" with Renin Angiotensin Aldosterone System Inhibitor use in Patients Enrolled in Trials for Heart Failure with Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Systematic Review.
Sign Up to like & getrecommendations! Published in 2023 at "Current vascular pharmacology"
DOI: 10.2174/1570161121666230314114549
Abstract: INTRODUCTION Angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), angiotensin receptor-neprilysin inhibitor (ARNI), and mineralocorticoid receptor antagonists (MRA) reduce mortality and hospitalizations in heart failure with reduced ejection fraction (HFrEF) but their use is limited… read more here.
Keywords: proportion trials; ckd grades; arb use; acei arb ... See more keywords